Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Globally, the human respiratory syncytial virus (hRSV) is the major cause of lower respiratory tract infections (LRTIs) in infants and children younger than 2 years old. Furthermore, the number of hospitalizations due to LRTIs has shown a sustained increase every year due to the lack of effective vaccines against hRSV. Thus, this virus remains as a major public health and economic burden worldwide. The lung pathology developed in hRSV-infected humans is characterized by an exacerbated inflammatory and Th2 immune response. In order to rationally design new vaccines and therapies against this virus, several studies have focused in elucidating the interactions between hRSV virulence factors and the host immune system. Here, we discuss the main features of hRSV biology, the processes involved in virus recognition by the immune system and the most relevant mechanisms used by this pathogen to avoid the antiviral host response.

Original publication

DOI

10.4161/viru.32225

Type

Journal article

Journal

Virulence

Publication Date

2014

Volume

5

Pages

740 - 751

Keywords

adaptive immune response, innate immune response, respiratory syncytial virus, virulence proteins, Adaptive Immunity, Child, Child, Preschool, Genome, Viral, Humans, Immune Evasion, Immunity, Innate, Infant, Lymphocyte Activation, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human, Viral Proteins, Virulence Factors